Trademark Overview
On Tuesday, May 21, 2024, a trademark application was filed for EDVANCI with the United States Patent and Trademark Office. The USPTO has given the EDVANCI trademark a serial number of 98560473. The federal status of this trademark filing is PUBLICATION/ISSUE REVIEW COMPLETE as of Thursday, October 31, 2024. This trademark is owned by Actelion Pharmaceuticals Ltd. The EDVANCI trademark is filed in the Pharmaceutical Products category with the following description:
Human pharmaceutical preparations for the prevention and treatment of viral diseases, auto-immune and inflammatory diseases, alloimmune diseases, cardiovascular and pulmonary diseases, central nervous system diseases, peripheral neurological system diseases, pain, dermatologic diseases, gastro-intestinal diseases, infectious-related diseases, metabolic diseases, oncologic diseases, ophthalmic diseases, respiratory diseases, hematological diseases, urological diseases, maternal fetal disorders, digital ulcers